Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0019204 (
hepatocellular carcinoma
)
71,386
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
To investigate the significance of stanniocalcin-2 (STC2) expression in
hepatocellular carcinoma
(
HCC
) tissues and adjacent tissues. Levels of STC2 in
HCC
tissue were detected in 200
HCC
patients tissues and adjacent tissues as controls by immunohistochemistry technique (IHC) and reverse transcriptase-PCR (RT-PCR). Single factor analysis was used to study the relationship between expression of STC2 mRNA and protein and clinicopathological features of
HCC
. Multifactor Cox survival analysis was used to relationship between the expression of STC2 and overall survival of postoperative patients with
HCC
. IHC staining showed that the expression of
STC2 protein
rate was 81.00% (163/200). And the positive rate of adjacent tissues was 29.00% (58/200). Western blot showed that the expression of
STC2 protein
in
HCC
was significantly higher than that in the adjacent tissues (
P
<0.05). RT-PCR showed that the positive rates of STC2 mRNA expression in
HCC
were 75.50% (151/200), which was significantly higher than that in adjacent tissues 14.50% (29/200) (
P
<0.05). Both STC2 mRNA and protein expression are related to tumor diameter, stage, tumor metastasis, carcinoma emboli in the portal vein and the degree of tumor differentiation in
HCC
. The
HCC
patients with higher expression of STC2 had shorter median survival time. STC2 expression, tumor diameter, carcinoma emboli in the portal vein, tumor differentiation degree, and tumor stage were independent factors affecting the overall survival of postoperative patients. The high expression of STC2 mRNA and protein expression in
HCC
may be associated with the occurrence, development, and prognosis of
HCC
. STC2 may also be possible to help developing new therapeutic strategies for
HCC
.
...
PMID:Clinical significance of high expression of stanniocalcin-2 in hepatocellular carcinoma. 3096 72